Archives
(S)-(+)-Dimethindene maleate: Selective M2 Muscarinic Ant...
(S)-(+)-Dimethindene maleate: Selective M2 Muscarinic Antagonist for Research
Executive Summary: (S)-(+)-Dimethindene maleate (APExBIO, B6734) is a well-characterized small molecule with selective antagonism for muscarinic acetylcholine M2 and histamine H1 receptors, exhibiting minimal cross-reactivity with M1, M3, and M4 subtypes (APExBIO Product Page). Its molecular weight is 408.5 Da and it is water-soluble at ≥20.45 mg/mL. The compound is integral for dissecting muscarinic and histamine receptor signaling in autonomic, cardiovascular, and respiratory models (Gong et al., 2025). Recent studies underscore its utility in scalable regenerative workflows, particularly in extracellular vesicle (EV) production and cell therapy standardization. For optimal results, storage desiccated at room temperature is advised, and working solutions should be used promptly to maintain integrity.
Biological Rationale
(S)-(+)-Dimethindene maleate is designed for high specificity in receptor signaling studies. Its dual antagonism profile—targeting both M2 muscarinic acetylcholine receptors and H1 histamine receptors—enables researchers to parse distinct pathways involved in autonomic regulation, cardiovascular homeostasis, and respiratory function. The M2 receptor subtype predominates in cardiac tissue and plays a crucial role in cholinergic signaling, while H1 receptors mediate histamine-driven inflammatory and vascular responses (Gong et al., 2025). Selective inhibition of these targets allows for dissection of their contributions without confounding off-target effects.
Mechanism of Action of (S)-(+)-Dimethindene maleate
(S)-(+)-Dimethindene maleate operates as a competitive antagonist at the muscarinic acetylcholine M2 receptor, thereby blocking acetylcholine-mediated activation. This results in inhibition of downstream Gi/o protein-coupled signaling, reducing cAMP levels and modulating cardiac chronotropy and inotropy. Its affinity for M2 is significantly greater than for M1, M3, or M4 subtypes, minimizing interference with other muscarinic-mediated pathways. Additionally, it antagonizes the histamine H1 receptor, impeding histamine-induced calcium mobilization and vascular permeability. The dual action is quantifiable using radioligand binding assays and functional readouts such as tissue contractility and cellular cAMP assays (APExBIO).
Evidence & Benchmarks
- Demonstrates high-affinity binding to muscarinic M2 receptors (IC50 in low nanomolar range), with >10-fold selectivity over M1, M3, and M4 subtypes (APExBIO).
- Inhibits histamine H1 receptor-mediated responses in cell-based assays, confirmed by calcium flux and radioligand displacement (Gong et al., 2025).
- Maintains stability and potency when stored desiccated at room temperature for up to 12 months (APExBIO).
- Widely used in preclinical cardiovascular and respiratory models to delineate autonomic signaling and pharmacological modulation (Gong et al., 2025).
- Facilitates high-fidelity receptor selectivity profiling in translational research workflows (Related Article).
Applications, Limits & Misconceptions
(S)-(+)-Dimethindene maleate is applied in:
- Selective blockade of M2 muscarinic receptors in cardiac, neuronal, and respiratory research.
- Dissecting histamine H1-mediated processes in inflammation and vascular permeability.
- Optimizing and standardizing cell therapy and extracellular vesicle (EV) workflows, particularly for regenerative medicine applications (Gong et al., 2025).
- Profiling receptor selectivity for new drug candidates and establishing mechanistic baselines.
For a deeper discussion of advanced mechanistic insights and integration into translational EV workflows, see this article, which this dossier extends by providing a verified benchmark summary and product-specific workflow parameters.
Common Pitfalls or Misconceptions
- Not suitable for diagnostic or therapeutic use in humans; for research use only as per APExBIO guidelines.
- Long-term storage of aqueous solutions (>24 hours) leads to loss of potency—prepare fresh solutions for each experiment.
- Does not selectively block other muscarinic subtypes (M1, M3, M4) at working concentrations; cross-reactivity is minimal but not zero at supraphysiological doses.
- Cannot be used to infer direct effects on non-cholinergic or non-histaminergic pathways.
- Batch-to-batch purity and solubility are critical; always verify lot analysis before use in quantitative workflows.
Workflow Integration & Parameters
For receptor profiling, dissolve (S)-(+)-Dimethindene maleate at ≥20.45 mg/mL in sterile water. Filter sterilize if required. Use within 24 hours of preparation to ensure stability. In cellular assays, titrate to desired final concentrations (typically 1–1000 nM) based on receptor expression and tissue context. Store dry powder desiccated at room temperature and avoid repeated freeze-thaw cycles. For EV and cell therapy research, incorporate into receptor antagonist panels to dissect cholinergic and histaminergic contributions to cell signaling and vesicle release, as exemplified by scalable EV production protocols in Gong et al. (2025) (DOI). For further parameters and troubleshooting, this workflow guide is updated here with validated solubility and selectivity data.
Conclusion & Outlook
(S)-(+)-Dimethindene maleate from APExBIO (B6734) is a validated, high-purity research tool for selective antagonism of muscarinic M2 and histamine H1 receptors. Its robust selectivity and stability make it indispensable for pharmacological dissection in autonomic, cardiovascular, and respiratory research, as well as for translational workflows in regenerative medicine and scalable EV production. Future advances in AI-driven drug discovery and cell therapy will likely leverage such compounds as gold-standard benchmarks for receptor selectivity and pathway validation. For procurement and technical documentation, see the official product page.
For strategic outlooks on integrating this tool into scalable cell therapy and regenerative medicine, see this article, which this dossier clarifies by providing updated benchmarks and product-specific recommendations.